Constrained model-predictive thermal dose control for MRI-guided ultrasound thermal treatments (Invited Paper)

2005 ◽  
Author(s):  
Dhiraj Arora ◽  
Trent Perry ◽  
Daniel Cooley ◽  
Junyu Guo ◽  
Rock Hadley ◽  
...  
2005 ◽  
Vol 52 (2) ◽  
pp. 191-200 ◽  
Author(s):  
D. Arora ◽  
M. Skliar ◽  
R.B. Roemer

2005 ◽  
Vol 50 (8) ◽  
pp. 1919-1935 ◽  
Author(s):  
Dhiraj Arora ◽  
Daniel Cooley ◽  
Trent Perry ◽  
Mikhail Skliar ◽  
Robert B Roemer

2019 ◽  
Vol 131 (6) ◽  
pp. 1958-1965 ◽  
Author(s):  
Sean M. Munier ◽  
Eric L. Hargreaves ◽  
Nitesh V. Patel ◽  
Shabbar F. Danish

OBJECTIVEIntraoperative dynamics of magnetic resonance–guided laser-induced thermal therapy (MRgLITT) have been previously characterized for ablations of naive tissue. However, most treatment sessions require the delivery of multiple doses, and little is known about the ablation dynamics when additional doses are applied to heat-damaged tissue. This study investigated the differences in ablation dynamics between naive versus damaged tissue.METHODSThe authors examined 168 ablations from 60 patients across various surgical indications. All ablations were performed using the Visualase MRI-guided laser ablation system (Medtronic), which employs a 980-nm diffusing tip diode laser. Cases with multiple topographically overlapping doses with constant power were selected for this study. Single-dose intraoperative thermal damage was used to calculate ablation rate based on the thermal damage estimate (TDE) of the maximum area of ablation achieved (TDEmax) and the total duration of ablation (tmax). We compared ablation rates of naive undamaged tissue and damaged tissue exposed to subsequent thermal doses following an initial ablation.RESULTSTDEmax was significantly decreased in subsequent ablations compared to the preceding ablation (initial ablation 227.8 ± 17.7 mm2, second ablation 164.1 ± 21.5 mm2, third ablation 124.3 ± 11.2 mm2; p = < 0.001). The ablation rate of subsequent thermal doses delivered to previously damaged tissue was significantly decreased compared to the ablation rate of naive tissue (initial ablation 2.703 mm2/sec; second ablation 1.559 mm2/sec; third ablation 1.237 mm2/sec; fourth ablation 1.076 mm/sec; p = < 0.001). A negative correlation was found between TDEmax and percentage of overlap in a subsequent ablation with previously damaged tissue (r = −0.164; p < 0.02).CONCLUSIONSAblation of previously ablated tissue results in a reduced ablation rate and reduced TDEmax. Additionally, each successive thermal dose in a series of sequential ablations results in a decreased ablation rate relative to that of the preceding ablation. In the absence of a change in power, operators should anticipate a possible reduction in TDE when ablating partially damaged tissue for a similar amount of time compared to the preceding ablation.


2012 ◽  
Vol 2012 ◽  
pp. 1-11 ◽  
Author(s):  
E. Sassaroli ◽  
K. C. P. Li ◽  
B. E. O'Neill

Preclinical studies indicate that focused ultrasound at exposure conditions close to the threshold for thermal damage can increase drug delivery at the focal region. Although these results are promising, the optimal control of temperature still remains a challenge. To address this issue, computer-simulated ultrasound treatments have been performed. When the treatments are delivered without taking into account the cooling effect exerted by the blood flow, the resulting thermal dose is highly variable with regions of thermal damage, regions of underdosage close to the vessels, and areas in between these two extremes. When the power deposition is adjusted so that the peak thermal dose remains close to the threshold for thermal damage, the thermal dose is more uniformly distributed but under-dosage is still visible around the thermally significant vessels. The results of these simulations suggest that, for focused ultrasound, as for other delivery methods, the only way to control temperature is to adjust the average energy deposition to compensate for the presence of thermally significant vessels in the target area. By doing this, we have shown that it is possible to reduce the temperature heterogeneity observed in focused ultrasound thermal treatments.


2021 ◽  
Author(s):  
Madhu Jain

Laser interstitial thermal therapy (LITT) is a minimally invasive technique for destroying localized solid tumors by heating with light. An obstacle to widespread adoption of LITT is the lack of adequate control of heating of surrounding healthy tissue and prevention of tissue and fiber-tip charring. An LITT thermal dose controller was developed to address these issues. The goal of the controller is to deliver prescribed thermal dose at a target location in tissue in a present treatment time. The developed feedback controller has a cascade structure with primary thermal dose control loop continuously generating the reference temperature for the secondary, constrained, model predictive temperature controller. The performance of controller was evaluated in simulated linear and non-linear tissue models and in albumen phantoms. The control system demonstrated the ability to achieve treatment goals across all evaluation models by delivering 240 eq. min dose at 5 mm in various preset treatment times.


2021 ◽  
Author(s):  
Madhu Jain

Laser interstitial thermal therapy (LITT) is a minimally invasive technique for destroying localized solid tumors by heating with light. An obstacle to widespread adoption of LITT is the lack of adequate control of heating of surrounding healthy tissue and prevention of tissue and fiber-tip charring. An LITT thermal dose controller was developed to address these issues. The goal of the controller is to deliver prescribed thermal dose at a target location in tissue in a present treatment time. The developed feedback controller has a cascade structure with primary thermal dose control loop continuously generating the reference temperature for the secondary, constrained, model predictive temperature controller. The performance of controller was evaluated in simulated linear and non-linear tissue models and in albumen phantoms. The control system demonstrated the ability to achieve treatment goals across all evaluation models by delivering 240 eq. min dose at 5 mm in various preset treatment times.


Sign in / Sign up

Export Citation Format

Share Document